INM News and Press, InMed Pharmaceuticals Inc. From 09/09/22

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: gvictoria / Shutterstock.com InMed Pharmaceuticals (NASDAQ: INM ) stock is rocketing higher on Friday after the company revealed research and development (R&D) updates . According to the cannabis ...

InMed Pharmaceuticals (NASDAQ: INM) , a leader in the research, development and manufacturing of rare cannabinoids and cannabinoid analogs, is reporting an update on the company’s research/development and commercial activities. According to the update, the company is working to compl...

Canada-based InMed Pharmaceuticals Inc. ( NASDAQ: INM ) added ~23% in the pre-market trading Friday after the company disclosed its plans to reprioritize efforts on pharmaceutical drug development and cut financial exposure to Health & Wellness (“H&W”) ...

VANCOUVER, British Columbia, Sept. 08, 2022 (GLOBE NEWSWIRE) -- InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (Nasdaq: INM), a leader in the research, development and manufacturing of rare cannabinoids and cannabinoid analogs, today announces an updat...

3 Trending Penny Stocks to Add to Your Watchlist Right Now When it comes to investing in penny stocks, there are a lot of ups and downs. In a volatile market, penny stocks can be a great investment. However, you need to know what you’re doing in order to make money off of them. T...

InMed Pharmaceuticals ( NM ) will be consolidating al l of its issued and outstanding share capital on the basis of one for each twenty five pre‐consolidation shares in order to regain compliance with all of Nasdaq’s continued listing requirements. Company shares...

VANCOUVER, British Columbia, Aug. 23, 2022 (GLOBE NEWSWIRE) -- InMed Pharmaceuticals Inc. (“ InMed ” or the “ Company ”) (Nasdaq: INM), a leader in the research, development, manufacturing and commercialization of rare cannabinoids, today announces, p...

InMed Pharmaceuticals (NASDAQ: INM) , a leader in the research, development, manufacturing and commercialization of rare cannabinoids, today announced the appointment of Nicole Lemerond to its board of directors, effective immediately. Lemerond is a financial executive with over 25 years of...

VANCOUVER, British Columbia, Aug. 09, 2022 (GLOBE NEWSWIRE) -- InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (Nasdaq: INM), a leader in the research, development, manufacturing and commercialization of rare cannabinoids, is pleased to announce the app...

InMed Pharmaceuticals ( NASDAQ: INM ) on Monday said its phase 2 trial with its cannabinol-based cream for the treatment of skin disorder epidermolysis bullosa was recently expanded to include adolescents following a positive recommendation from a data safety board. INM st...